Literature DB >> 19959973

Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men.

Alex Carballo-Diéguez1, José Bauermeister, Ana Ventuneac, Curtis Dolezal, Kenneth Mayer.   

Abstract

RATIONALE: To explore age of onset of rectal douching among men who have sex with men (MSM) and reasons leading to and maintaining douching behavior; and to consider whether rectal douches containing microbicidal agents might be acceptable for men at HIV risk.
METHODS: In stage 1, we used qualitative methods to explore douching behavior in a sample of 20 MSM. Subsequently, we developed a structured questionnaire that was administered in stage 2 to 105 MSM.
RESULTS: More than half of participants who completed stage 1 douched during the trial despite having been advised not to do so. Of the 105 human immunodeficiency virus uninfected participants in stage 2, 51% reported using rectal douches in the prior 6 months; 47% douched before and 25% after anal intercourse. Most participants reported douching frequently or always. On average, men reported douching about 2 hours before or 1 hour following intercourse. Average age of onset was late 20s. Most men who douched wanted to be clean or were encouraged to douche by their partners. Some men thought douching after sex could prevent sexually transmitted infections.
CONCLUSION: Rectal douching appears to be a popular behavior among men who have receptive anal intercourse. It is necessary to identify harmless douches. If human immunodeficiency virus or sexually transmitted infections preventive douches can be developed, rectal douching before or following sexual intercourse could become an important additional prevention tool. To reshape an existing behavior to which some men strongly adhere, like douching, by suggesting use of 1 type of douche over another may be more successful than trying to convince MSM to engage in behaviors they never practiced before or those they resist (e.g., condom use).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19959973      PMCID: PMC2891180          DOI: 10.1097/OLQ.0b013e3181bf9b2d

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  19 in total

1.  Vaginal douching and adverse health effects: a meta-analysis.

Authors:  J Zhang; A G Thomas; E Leybovich
Journal:  Am J Public Health       Date:  1997-07       Impact factor: 9.308

Review 2.  Colon cleansing for diagnostic and surgical procedures: polyethylene glycol-electrolyte lavage solution.

Authors:  J A DiPalma; C E Brady
Journal:  Am J Gastroenterol       Date:  1989-09       Impact factor: 10.864

3.  Vaginal douching, condom use, and sexually transmitted infections among Chinese female sex workers.

Authors:  Bo Wang; Xiaoming Li; Bonita Stanton; Hongmei Yang; Xiaoyi Fang; Ran Zhao; Baiqing Dong; Yuejiao Zhou; Wei Liu; Shaoling Liang
Journal:  Sex Transm Dis       Date:  2005-11       Impact factor: 2.830

4.  Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.

Authors:  Peter V Chin-Hong; Eric Vittinghoff; Ross D Cranston; Lynette Browne; Susan Buchbinder; Grant Colfax; Maria Da Costa; Teresa Darragh; Dana Jones Benet; Franklyn Judson; Beryl Koblin; Kenneth H Mayer; Joel M Palefsky
Journal:  J Natl Cancer Inst       Date:  2005-06-15       Impact factor: 13.506

Review 5.  Douching: a problem for adolescent girls and young women.

Authors:  J S Merchant; K Oh; L V Klerman
Journal:  Arch Pediatr Adolesc Med       Date:  1999-08

6.  Hepatitis C virus infection in a male homosexual cohort: risk factor analysis.

Authors:  O K Ndimbie; L A Kingsley; S Nedjar; C R Rinaldo
Journal:  Genitourin Med       Date:  1996-06

7.  HIV infection and vaginal douching in central Africa.

Authors:  G Gresenguet; J K Kreiss; M K Chapko; S L Hillier; N S Weiss
Journal:  AIDS       Date:  1997-01       Impact factor: 4.177

8.  Safety and effectiveness of large-volume enema solutions.

Authors:  Marilee Schmelzer; Lawrence R Schiller; Richard Meyer; Susan M Rugari; Patti Case
Journal:  Appl Nurs Res       Date:  2004-11       Impact factor: 2.257

9.  A comparison of risk factors for human immunodeficiency virus and hepatitis B virus infections in homosexual men.

Authors:  D E Koziol; A J Saah; N Odaka; A Muñoz
Journal:  Ann Epidemiol       Date:  1993-07       Impact factor: 3.797

10.  Hepatitis B in homosexual men: prevalence of infection and factors related to transmission.

Authors:  M T Schreeder; S E Thompson; S C Hadler; K R Berquist; A Zaidi; J E Maynard; D Ostrow; F N Judson; E H Braff; T Nylund; J N Moore; P Gardner; I L Doto; G Reynolds
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

View more
  17 in total

1.  Enema ion compositions for enhancing colorectal drug delivery.

Authors:  Katharina Maisel; Sumon Chattopadhyay; Thomas Moench; Craig Hendrix; Richard Cone; Laura M Ensign; Justin Hanes
Journal:  J Control Release       Date:  2015-04-30       Impact factor: 9.776

2.  An event-level comparison of risk-related sexual practices between black and other-race men who have sex with men: condoms, semen, lubricant, and rectal douching.

Authors:  Sarah K Calabrese; Joshua G Rosenberger; Vanessa R Schick; David S Novak; Michael Reece
Journal:  AIDS Patient Care STDS       Date:  2013-02       Impact factor: 5.078

3.  Preparing for rectal microbicides: sociocultural factors affecting product uptake among potential South American users.

Authors:  Jerome T Galea; Janni J Kinsler; John Imrie; César R Nureña; Lucía Ruiz; Luis Fernando Galarza; Jorge Sánchez; William E Cunningham
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

4.  Rectal Douching and Microbicide Acceptability among Young Men who Have Sex with Men.

Authors:  Ryan C Tingler; Daniel Connochie; José A Bauermeister
Journal:  AIDS Behav       Date:  2020-05

5.  Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche.

Authors:  Alex Carballo-Dieguez; Rebecca Giguere; Cody Lentz; Curtis Dolezal; Edward J Fuchs; Craig W Hendrix
Journal:  AIDS Behav       Date:  2019-06

6.  Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema.

Authors:  Thuy Hoang; Abhijit A Date; Jairo Ortiz Ortiz; Ting-Wei Young; Sabrine Bensouda; Peng Xiao; Mark Marzinke; Lisa Rohan; Edward J Fuchs; Craig Hendrix; Sanjeev Gumber; Francois Villinger; Richard A Cone; Justin Hanes; Laura M Ensign
Journal:  Eur J Pharm Biopharm       Date:  2018-05-24       Impact factor: 5.571

Review 7.  Rectal Douching Associated with Receptive Anal Intercourse: A Literature Review.

Authors:  Alex Carballo-Diéguez; Cody Lentz; Rebecca Giguere; Edward J Fuchs; Craig W Hendrix
Journal:  AIDS Behav       Date:  2018-04

8.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12

9.  Anal Douche Practices and Willingness to Use a Rectal Microbicide Enema for HIV Prevention and Associated Factors Among an Internet Sample of HIV-Negative and HIV-Discordant Male Couples in the US.

Authors:  Jason W Mitchell; Amber I Sophus; Ji-Young Lee; Andrew E Petroll
Journal:  AIDS Behav       Date:  2016-11

10.  Rectal douching and implications for rectal microbicides among populations vulnerable to HIV in South America: a qualitative study.

Authors:  Jerome T Galea; Janni J Kinsler; John Imrie; César R Nureña; Jorge Sánchez; William E Cunningham
Journal:  Sex Transm Infect       Date:  2013-08-21       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.